Acurx Pharmaceuticals Cuts Losses and Advances Clinical Trials: New Patent and Phase 3 Planning Highlight a Pivotal Year
Market Chameleon (Mon, 16-Mar 10:29 AM)
ACXP Advances Groundbreaking Antibiotic Program with Lower R&D Spend and Solid Cash Position
Market Chameleon (Fri, 13-Mar 7:29 AM)
Acurx’s Groundbreaking Ibezapolstat Trial Targets Both Treatment and Prevention of Recurrent C. difficile Infection
Market Chameleon (Tue, 10-Mar 10:29 AM)
